Adial Pharmaceuticals Inc (NASDAQ:ADIL) does about 7.38M shares in volume on a normal day but saw 14783827 shares change hands in the recent trading day. The company now has a market cap of 5.29M USD. Its current market price is $0.34, marking a decrease of -28.67% compared to the previous close of $0.47. The 52 week high reached by this stock is $3.00 whilst the lowest price level in 52 weeks is $0.22.
The consensus objective for the share price is $2.00, suggesting that the stock has a potential upside of 83.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 14, 2024 when Rodman & Renshaw initiated the stock to “Buy” and issued a price target of $8.
The current price level is -25.12%, -42.96%, and -60.37% away from its SMA20, SMA50, and SMA200 respectively, with the ADIL price moving above the 50-day SMA on current market day. Adial Pharmaceuticals Inc (ADIL) stock is up 36.55% over the week and -50.72% over the past month. Its price is -70.61% year-to-date and -66.82% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.22 and -0.55 for whole year.
To reach the target analysts have set, the stock logically needs to grow 83.0 percent from here.
Outstanding shares total 15.78M with insiders holding 3.41% of the shares and institutional holders owning 3.64% of the company’s common stock. The company has a return on investment of -420.83% and return on equity of -217.01%. The beta has a value of 1.12. Price to book ratio is 1.05.
